Christopher Hite sold $7.3M of RPRX stock

Christopher Hite, EVP & Chairman, Partnering of Royalty Pharma plc (RPRX), sold 130,000 shares of RPRX stock worth $7.3M, per an SEC Form 4 filed Jul 2, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jun 30, 2026, 2 days before it was made public.

RPRX has moved +23.0% since the trade date, from $56.07 to $68.97 (Nov 12, 2026 close).